SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Stericycle, Inc. (SRCL) , 前瞻盈利收益率 5.65%. PEG 1.38.
本页证实的标准:
- VALUE (35/100, 未通过) — 综合估值评分低于60/100的通过门槛。
- 前瞻市盈率 17.7
- PEG 比率 1.38 — 介于1.0–2.0之间，表明相对于增长的估值适中。
- 分析师共识目标价 $56.33 (-9.1% 下行风险) — 轻微下行风险 — 市场可能已超前于分析师预期。
SharesGrow 综合评分： 32/100 其中 0/7 项标准通过。
SharesGrow 7-Criteria Score
✗
价值
35/100
Price-to-Earnings & upside
Proven by this page
✗
健康
17/100
Debt-to-Equity & liquidity
→ Health
估值概览 — SRCL
估值倍数
P/E (TTM)0.0
前瞻 P/E17.7
PEG 比率1.38
前瞻 PEG1.38
P/B 比率0.00
P/S 比率2.15
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.23
前瞻 EPS（预估）$3.50
每股账面价值$0.00
每股营收$28.78
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
Forward Earnings Yield5.65%
股息收益率0.00%
分析师目标价$56.33 (-9.1%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2014 |
$3.79 |
$2.56B |
$326.46M |
12.8% |
| 2015 |
$2.96 |
$2.99B |
$267.08M |
8.9% |
| 2016 |
$2.08 |
$3.56B |
$205.97M |
5.8% |
| 2017 |
$0.27 |
$3.58B |
$42.4M |
1.2% |
| 2018 |
$-2.81 |
$3.49B |
$-244.7M |
-7% |
| 2019 |
$-3.80 |
$3.31B |
$-346M |
-10.5% |
| 2020 |
$-0.61 |
$2.68B |
$-55.9M |
-2.1% |
| 2021 |
$-0.29 |
$2.65B |
$-26.8M |
-1% |
| 2022 |
$0.61 |
$2.7B |
$56M |
2.1% |
| 2023 |
$-0.23 |
$2.66B |
$-21.4M |
-0.8% |
